Provider Resources

To recieve more information about Greenbrook & TMS therapy:

About TMS Therapy

8 Things to Know

  1. FDA-cleared for treatment of Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), & smoking cessation

  2. Likelihood of patients with MDD achieving remission is limited and declines with each successive medication trial. After 2 medication trials, there is approximately a 16 percent chance of remission with a new trial.* Studies have shown the following TMS rates**: 
    62% Response   |   41% Remission   |   62.5% Durability ***

  3. Appropriate for use either as an adjunct or as a monotherapy

  4. Well-tolerated, non-invasive, & low-risk treatment for MDD, requiring no post-treatment downtime. Occasional side effects (scalp sensitivity or headaches)

  5. Performed in an office setting — average treatment plan usually consists of 20 minute treatment sessions performed 5 days each week for 6 consecutive weeks

  6. Covered by most major insurance; Medicaid & Medicare accepted in various locations (Call 855-940-4867 for more information)

  7. Works via magnetic pulses that induce electrical currents, stimulating neurons to bring about therapeutic effect. TMS for MDD targets the left dorsolateral prefrontal cortex. TMS for OCD delivers bilateral stimulation to the medial prefrontal cortex and cingulate cortex.

  8. Possible Contraindications:
    - History of seizures
    - Implanted medical devices like a pacemaker
    - Non-removable metallic implants above the neckline

StarD Study; Rush et al., Am. J Psychiatry 2006, PMID 17074942
** A Multisite, Naturalistic, Observational Study of TMS; Dunner et al., J Clin Psychiatry 2014, PMID 25271871
*** 12-mo follow-up measured via IRS-SR scale with a cohort of 120 patients

View TMS at a Glance as a PDF >

Identifying a Candidate: TMS for MDD

TMS is FDA-indicated for Major Depressive Disorder (MDD) after one medication trial of adequate dose and duration. We recommend presenting MDD patients for TMS consultation after they've tried 2 medications, as well as evidence-based therapy, in order to meet typical insurance criteria.

Learn more with our Identifying a TMS Candidate sheet  >

How TMS Works

Works via magnetic pulses that induce electrical currents, stimulating neurons to bring about therapeutic effect. 

Learn more with our Mechanism of Action sheet >


TMS therapy with the H7 coil is an FDA-cleared treatment option for Obsessive-Compulsive Disorder (OCD).

Learn more with our TMS for OCD sheet >

Learn via Video

About Greenbrook TMS

TMS Mechanism of Action

Treatment Mapping: Motor Threshold Process


Greenbrook TMS Insurance Coverage

Patient Stories

Refer for a Consultation

After their no-cost consultation, your patient will recieve a psychiatric evaluation from one our our psychiatrists specializing in TMS. 
We look forward to working with you to support those in our community suffering with MDD and OCD. 

Educational Opportunities


TMS Therapy − An Overview & Update

NEI CME credit
Presenter: Steven Harvey, MD, Regional Medical Director - St. Louis, MO
Date & Time: November 13th at 12pm CST / 1pm EST (one hour)

On-Demand CEU/CME Portal − Coming Soon!

Regional Account Managers

Our knowledgeable Regional Account Managers are here to help you with any questions you may have about Greenbrook, TMS, or referral considerations.
Click here to get in touch with a local member of our team >

Learn More

To recieve more information about Greenbrook & TMS therapy: